Analysis reveals that S-lactoylglutathione affects glyceraldehyde 3P dehydrogenase activity, indicating potential metabolic control.
In this study, the involvement of S,D-lactoylglutathione in the modification of the iso-form 1 of cytosolic glyceraldehyde 3P dehydrogenase (GAPC1) is examined. Incuba-tion of GAPC1 with S,D-lactoylglutathione resulted in inhibition of enzyme activity. The inhibitory effect was concentration-dependent and increased at alkaline pHs. Furthermore, inhibition of GAPC1 by S,D-lactoylglutathione was favored by oxidative conditions and reversed by reduction with dithiothreitol. Analyses of the S,D-lactoylglutathione-treated protein by nano LC-MS/MS revealed S-glutathionylation of its two Cys residues and N-lactoylation of six Lys residues. Pro-tein structure prediction showed that the double S-glutathionylation is accommodated by the GAPC1 catalytic pocket which likely explains enzyme inhibition. N-lactoylated sites overlap partially with previously reported N-acetylated sites at the surface of the GAPC1 tetramer. The efficiency of cytosolic glutaredoxin and thioredoxin isoforms was tested for reversing the S,D-lactoylglutathione-induced modification. In these as-says, recovery of GAPC1 activity after inhibition by S,D-lactoylglutathione treatment was used as indicator of efficiency. Results show that both types of redoxins were able to reverse inhibition. We propose a model describing the mechanisms involved in the two types of post-translational modification found on GAPC1 following exposure to S,D-lactoylglutathione. The possible involvement of these findings for the control over glycolytic metabolism is discussed.
No takes yet. Share an insight, caveat, or question.
Clément et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: